Background and study aims: Advances in endoscope design have allowed high-quality imaging using small-caliber endoscopes (< 6 mm), and these have been proposed as providing an accurate modality for evaluating esophageal varices in several small studies. We aimed to evaluate the accuracy and interobserver agreement of small-caliber esophagogastroduodenoscopy (EGD) compared with conventional EGD for evaluating esophageal varices in a large prospective cohort.
Patients and methods: A total of 115 patients with end-stage liver disease and/or portal hypertension were prospectively enrolled into the study. EGD procedures were performed using conventional (8.6-mm) and small-caliber (4.9-mm) endoscopes, back to back and under standard sedation, by two different endoscopists. Esophageal varices were graded at the time of EGD (the “real-time” grade); and by retrospective review of photographs by three endoscopists, when a “consensus” grade (i. e. a grading agreed by two out of the three endoscopists) was used as the final result.
Results: Of the 115 patients, 33 patients (29 %) were classified as Child’s class A, 47 patients (41 %) as Child’s class B, and 35 patients (30 %) as Child’s class C. The mean model for end-stage liver disease (MELD) score was 13.6. Thirty-six patients (31 %) had undergone previous ligation of esophageal varices. Compared with conventional EGD, the accuracy of small-caliber EGD for esophageal varices grading was 94 % (consensus grade) and 95 % (real-time grade). Excellent concordance was demonstrated between real-time grade and consensus grade, with a kappa of 0.95 for both types of EGD. There was excellent interobserver agreement between endoscopists, regardless of the type of EGD. The severity of hepatic dysfunction and the presence or absence of a history of previous esophageal varices ligation did not have any impact on the accuracy or interobserver agreement.
Conclusions: Small-caliber EGD performed under sedation via oral intubation is a highly accurate and reliable modality for evaluating esophageal varices in patients with end-stage liver disease and/or portal hypertension, regardless of the degree of hepatic dysfunction or history of previous esophageal varices ligation.
References
-
1
Chalasani N, Imperiale T F, Ismail A. et al .
Predictors of large esophageal varices in patients with cirrhosis.
Am J Gastroenterol.
1999;
94
3285-3291
-
2
Zaman A, Becker T, Lapidus J. et al .
Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage.
Arch Intern Med.
2001;
161
2564-2570
-
3
Predictors of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices.
N Engl J Med.
1988;
319
983-989
-
4
Gores G J, Weisner R H, Dickson E R. et al .
Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence in survival.
Gastroenterology.
1989;
96
1552-1559
-
5
Bosch J, Abraldes J G, Groszmann R.
Current management of portal hypertension.
J Hepatol.
2003;
38 Suppl 1
S54-S68
-
6
Graham D Y, Smith J L.
The course of patients after variceal hemorrhage.
Gastroenterology.
1981;
80
800-809
-
7
McCormick P A, O’Keffe C.
Improving prognosis following a first variceal hemorrhage over four decades.
Gut.
2001;
49
682-685
-
8
Grace N D, Groszmann R J, Garcia-Tsao G. et al .
Portal hypertension and variceal bleeding: an AASLD single topic symposium.
Hepatology.
1998;
28
868-880
-
9
de Franchis R.
Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.
J Hepatol.
2005;
43
167-176
-
10
Grace N D.
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.
Am J Gastroenterol.
1997;
92
1081-1091
-
11
Teran J C, Imperiale T F, Mullen K D. et al .
Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis.
Gastroenterology.
1997;
112
473-482
-
12
Arguedas M R, Heudebert G R, Eloubeidi M A. et al .
Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
Am J Gastroenterol.
2002;
97
2441-2452
-
13
Saab S, DeRosa V, Nieto J. et al .
Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
Am J Gastroenterol.
2003;
98
763-770
-
14
Spiegel B M, Targownik L, Dulai G S. et al .
Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective?.
Hepatology.
2003;
37
366-377
-
15
Assy N, Rosser B G, Grahame G R, Minuk G Y.
Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis.
Gastrointest Endosc.
1999;
49
690-694
-
16
Zaman A, Hapke R, Sahagun G, Katon R M.
Unsedated peroral endoscopy with a video ultrathin endoscope: patient acceptance, tolerance, and diagnostic accuracy.
Am J Gastroenterol.
1998;
93
1260-1263
-
17
Gorelick A B, Inadomi J M, Barnett J L.
Unsedated small-caliber esophagogastro-duodenoscopy (EGD): less expensive and less time-consuming than conventional EGD.
J Clin Gastroenterol.
2001;
33
210-214
-
18
Faulx A L, Catanzaro A, Zyzanski S. et al .
Patient tolerance and acceptance of unsedated ultrathin esophagoscopy.
Gastrointest Endosc.
2002;
55
620-623
-
19
Saeian K, Staff D M, Vasilopoulos S. et al .
Unsedated transnasal endoscopy accurately detects Barrett’s metaplasia and dysplasia.
Gastrointest Endosc.
2002;
56
472-478
-
20
Garcia R T, Cello J P, Nguyen M H. et al .
Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial.
Gastroenterology.
2003;
125
1606-1612
-
21
Saeian K, Staff D, Knox J. et al .
Unsedated transnasal endoscopy: a new technique for accurately detecting and grading esophageal varices in cirrhotic patients.
Am J Gastroenterol.
2002;
97
2246-2249
-
22
Madhotra R, Mokhashi M, Willner I. et al .
Prospective evaluation of a
3. 1-mm battery-powered esophagoscope in screening for esophageal varices in cirrhotic patients.
Am J Gastroenterol.
2003;
98
807-812
-
23
Darwin P, Zangara J, Heller T. et al .
Unsedated esophagoscopy for the diagnosis of esophageal varices in patients with cirrhosis.
Endoscopy.
2000;
32
971-973
-
24
Anand C P, Lindsey J, Oprescu F. et al .
Unsedated peroral small-caliber endoscopy for screening of cirrhotics for esophageal varices.
Gastrointest Endosc.
2004;
59
AB239
-
25
Liu J, Singh H, White P F.
Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation.
Anesthesiology.
1996;
84
64-69
-
26
Thuluvath P J, Krishnan A.
Primary prophylaxis of variceal bleeding.
Gastrointest Endosc.
2003;
58
558-567
-
27 Exact confidence limits for p. In: Lentner C, Lentner C, Wink A (eds) Geigy Scientific Tables. Vol. 2. West Caldwell, New Jersey; CIBA-Geigy Corp 1982: 89-102
-
28 Dufour M C. Chronic liver disease and cirrhosis. In: Everhart JE (eds) Digestive diseases in the United States: epidemiology and impact. NIH Publication no. 94; 1447. Washington, DC; US Dept of Health and Human Services 1994: 615-645
-
29
Kim W R, Gross Jr J B, Poterucha J J. et al .
Outcome of hospital care of liver disease associated with hepatitis C in the United States.
Hepatology.
2001;
33
201-206
-
30
Gralnek I M, Jensen D M, Kovacs T OG. et al .
The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy.
Hepatology.
1999;
29
44-50
-
31 Saadatmand F, Stinson F S, Grant B F. et al .Surveillance Report No. 52: Liver cirrhosis mortality in the United States, 1970 - 96. Rockville, MD; National Institute on Alcohol Abuse and Alcoholism, Division of Biometry and Epidemiology 1999
-
32
Groszmann R J, Garcia-Tsao G, Bosch J. et al .
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
N Engl J Med.
2005;
353
2254-2261
S. Pungpapong, MD
Department of Gastroenterology and Hepatology
Mayo Clinic College of Medicine
4500 San Pablo Road
Jacksonville
Florida 32224
USA
Fax: +1-904-953-7260
Email: pungpapong.surakit@mayo.edu
